392 related articles for article (PubMed ID: 33359741)
21. [Clinical analysis of 76 cases of sentinel lymph node detection in cervical cancer and endometrial cancer].
Liang SC; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2017 Sep; 52(9):605-611. PubMed ID: 28954449
[No Abstract] [Full Text] [Related]
22. Similar distribution of pelvic sentinel lymph nodes and nodal metastases in cervical and endometrial cancer. A prospective study based on lymphatic anatomy.
Lührs O; Bollino M; Ekdahl L; Lönnerfors C; Geppert B; Persson J
Gynecol Oncol; 2022 Jun; 165(3):466-471. PubMed ID: 35437170
[TBL] [Abstract][Full Text] [Related]
23. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X
Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
Bizzarri N; Luigi PA; Ferrandina G; Zannoni GF; Carbone MV; Fedele C; Teodorico E; Gallotta V; Gueli Alletti S; Chiantera V; Fagotti A; Scambia G; Fanfani F
J Cancer Res Clin Oncol; 2021 Mar; 147(3):649-659. PubMed ID: 33000339
[TBL] [Abstract][Full Text] [Related]
25. Potential risks in sentinel lymph node biopsy for cervical cancer: a single-institution pilot study.
Tu H; Wan T; Zhang X; Gu H; Feng Y; Huang H; Liu J
World J Surg Oncol; 2020 Jun; 18(1):133. PubMed ID: 32552905
[TBL] [Abstract][Full Text] [Related]
26. Use of methylene blue dye for sentinel lymph node mapping in early-stage gynecological cancers - An option for low resource settings.
Singh N; Agrawal S
J Cancer Res Ther; 2022; 18(4):1088-1092. PubMed ID: 36149165
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
[TBL] [Abstract][Full Text] [Related]
28. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
[TBL] [Abstract][Full Text] [Related]
29. Indications and techniques for robotic pelvic and para-aortic lymphadenectomy with sentinel lymph node mapping in gynecologic oncology.
Wisner KPA; Ahmad S; Holloway RW
Best Pract Res Clin Obstet Gynaecol; 2017 Nov; 45():83-93. PubMed ID: 28533155
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications.
El-Ghobashy AE; Saidi SA
Eur J Surg Oncol; 2009 Jul; 35(7):675-85. PubMed ID: 18980825
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
[TBL] [Abstract][Full Text] [Related]
32. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
[TBL] [Abstract][Full Text] [Related]
33. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
34. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
[TBL] [Abstract][Full Text] [Related]
35. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
[TBL] [Abstract][Full Text] [Related]
36. Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging.
Casarin J; Multinu F; Pasupathy K; Weaver A; McGree M; Tortorella L; Torres D; Kumar A; Langstraat C; Huang Y; Ghezzi F; Mariani A; Glaser G
Ann Surg Oncol; 2018 Nov; 25(12):3692-3698. PubMed ID: 30116949
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
[TBL] [Abstract][Full Text] [Related]
38. Combining Indocyanine Green and Tc
Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
[TBL] [Abstract][Full Text] [Related]
39. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
[TBL] [Abstract][Full Text] [Related]
40. The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer.
Bjørnholt SM; Sponholtz SE; Mogensen O; Bouchelouche K; Parner ET; Neumann G; Jochumsen KM; Hamid BH; Davidsen MB; Bjørn SF; Dahl K; Jensen PT
Gynecol Oncol; 2023 Apr; 171():121-128. PubMed ID: 36893488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
